Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-25 @ 2:15 PM
Study NCT ID:
NCT03487666
Status:
COMPLETED
Last Update Posted:
2024-12-03
First Post:
2018-03-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
Sponsor:
Georgetown University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-02
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-20
First Submit QC Date:
None
Study First Post Date:
2018-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-21
Results First Submit QC Date:
None
Results First Post Date:
2024-12-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-07
Last Update Post Date:
2024-12-03
Last Update Post Date Type:
ACTUAL